ABVC BIOPHARMA, INC. Quarterly Common Stock, Shares, Issued from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Abvc Biopharma, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q3 2010 to Q3 2024.
  • Abvc Biopharma, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 12.7M shares, a 164% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 12.7M +7.89M +164% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 12.1M +8.74M +264% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 10.7M -22.4M -67.7% Mar 31, 2024 10-Q 2024-05-17
Q4 2023 7.94M +4.65M +142% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 4.82M -27.8M -85.2% Sep 30, 2023 10-Q 2023-11-15
Q2 2023 3.31M -29M -89.8% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 33.1M +2.77M +9.15% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 3.29M -21.1M -86.5% Dec 31, 2022 10-K 2024-03-13
Q3 2022 32.6M +4.7M +16.8% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 32.3M +7.84M +32% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 30.3M +5.89M +24.1% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 24.4M 0 0% Dec 31, 2021 10-K 2023-03-31
Q3 2021 27.9M +7.54M +37% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 24.5M +4.98M +25.6% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 24.4M +4.93M +25.3% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 24.4M +23.8M +3686% Dec 31, 2020 10-K 2022-03-31
Q3 2020 20.4M +916K +4.7% Sep 30, 2020 10-Q 2020-11-17
Q2 2020 19.5M +1.37M +7.54% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 19.5M +1.79M +10.1% Mar 31, 2020 10-Q 2020-06-30
Q4 2019 645K -11.2M -94.6% Dec 31, 2019 10-Q 2022-11-14
Q3 2019 19.5M -194M -90.9% Sep 30, 2019 10-Q 2019-11-18
Q2 2019 18.1M -196M -91.5% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 17.7M -196M -91.7% Mar 31, 2019 10-Q 2019-05-28
Q4 2018 11.9M -202M -94.4% Dec 31, 2018 10-K 2020-05-15
Q3 2018 214M +180K +0.08% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 214M +180K +0.08% Jun 30, 2018 10-Q 2018-08-20
Q1 2018 214M +180K +0.08% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 214M +2.93M +1.39% Dec 31, 2017 10-K 2020-05-15
Q3 2017 214M +2.93M +1.39% Sep 30, 2017 10-KT 2018-04-13
Q2 2017 214M +4.39M +2.1% Jun 30, 2017 10-Q/A 2018-03-19
Q1 2017 214M +4.99M +2.39% Mar 31, 2017 10-Q/A 2018-03-19
Q4 2016 211M +145M +222% Dec 31, 2016 10-Q/A 2018-03-19
Q3 2016 211M +44.5M +26.8% Sep 30, 2016 10-Q/A 2018-03-19
Q2 2016 209M +155M +283% Jun 30, 2016 10-Q/A 2017-02-22
Q1 2016 209M +154M +282% Mar 31, 2016 10-Q/A 2016-05-17
Q4 2015 65.4M +10.8M +19.9% Dec 31, 2015 10-Q 2016-02-23
Q3 2015 166M +166M Sep 30, 2015 10-K/A 2017-09-22
Q2 2015 54.6M 0 0% Jun 30, 2015 10-Q 2015-08-19
Q1 2015 54.6M 0 0% Mar 31, 2015 10-Q/A 2015-06-05
Q4 2014 54.6M 0 0% Dec 31, 2014 10-Q 2015-04-17
Q3 2014 11.1K* -54.6M Sep 30, 2014 10-Q 2016-02-23
Q2 2014 54.6M 0 0% Jun 30, 2014 10-Q 2015-04-17
Q1 2014 54.6M 0 0% Mar 31, 2014 10-Q 2015-04-17
Q4 2013 54.6M 0 0% Dec 31, 2013 10-Q 2015-04-17
Q3 2013 54.6M +40.4M +286% Sep 30, 2013 10-Q 2015-04-17
Q2 2013 54.6M +53.2K +0.1% Jun 30, 2013 10-Q 2015-04-16
Q1 2013 54.6M +38.3M +234% Mar 31, 2013 10-Q 2015-04-16
Q4 2012 54.6M +38.3M +234% Dec 31, 2012 10-Q 2015-04-16
Q3 2012 14.2M 0 0% Sep 30, 2012 10-K 2015-04-16
Q2 2012 54.5M +43.9M +412% Jun 30, 2012 10-Q/A 2012-08-20
Q1 2012 16.3M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 16.3M Dec 31, 2011 10-Q 2012-02-21
Q3 2011 14.2M -18.8M -57% Sep 30, 2011 10-K 2015-04-15
Q2 2011 10.7M Jun 30, 2011 10-Q/A 2011-09-08
Q3 2010 32.9M Sep 30, 2010 10-K/A 2011-12-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.